These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 19581141)
1. Use of gastroprotective drugs in patients receiving low-dose aspirin. Luk HH J Chin Med Assoc; 2009 Jul; 72(7):356-61. PubMed ID: 19581141 [TBL] [Abstract][Full Text] [Related]
2. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510 [TBL] [Abstract][Full Text] [Related]
3. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis. Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055 [TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493 [TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin. Nakashima S; Ota S; Arai S; Yoshino K; Inao M; Ishikawa K; Nakayama N; Imai Y; Nagoshi S; Mochida S World J Gastroenterol; 2009 Feb; 15(6):727-31. PubMed ID: 19222098 [TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
8. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study. Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019 [TBL] [Abstract][Full Text] [Related]
10. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP; J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778 [TBL] [Abstract][Full Text] [Related]
11. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Taha AS; McCloskey C; Prasad R; Bezlyak V Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798 [TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease. Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589 [TBL] [Abstract][Full Text] [Related]
13. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related]
14. Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users. Sugano K Curr Pharm Des; 2015; 21(35):5082-8. PubMed ID: 26369684 [TBL] [Abstract][Full Text] [Related]
15. Primary prevention of ulcers in patients taking aspirin or NSAIDs. Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052 [TBL] [Abstract][Full Text] [Related]
16. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
17. Prevention of damage induced by aspirin in the GI tract. Scheiman JM Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):153-62. PubMed ID: 22542153 [TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]